Genomize in Scientific Articles

You are here:
Orange document icon with pencil
Challenging Genetic Diagnosis in Siblings With Primordial Dwarfism, Muscle Wasting, Osteogenesis Imperfecta, Craniofacial Dysmorphism, and Ectodermal Anomalies

Using SEQ Platform genome analysis, Önel et al. (2026) found an ANKLE2 enhancer variant shared by three siblings with primordial dwarfism, while differing mutations in five other genes explained their variable features.

Orange document icon with pencil
Prevalence, associated clinical factors, and genetic characteristics of endocrinopathies in common variable immunodeficiency: a retrospective study of 95 adult patients from a single tertiary care center.

Yigitdol et al. (2026) found endocrine disorders in one third of 95 adults with common variable immunodeficiency, an antibody deficiency, and used SEQ Platform immune gene panel analysis to identify five pathogenic or likely pathogenic variants.

Orange document icon with pencil
Clinical spectrum and survival outcomes of malignancies in pediatric patients with inborn errors of immunity.

Deveci Demirbas et al. (2026) showed that in two thirds of 67 children with inborn errors of immunity and cancer, the cancer was diagnosed first, mostly as advanced lymphoma, with Genomize-SEQ exome analysis supporting genetic diagnosis.

Orange document icon with pencil
MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer.

Koç et al. (2026) identified MCPH1 as the most frequently affected candidate gene, including one likely pathogenic truncating variant, among 185 unresolved hereditary breast cancer patients analyzed with SEQ Platform.

Orange document icon with pencil
Generalized Dystonia With Cervical Predominance in a Patient With a De Novo TCF20 Variant

Kilic et al. (2026) used SEQ Platform whole-genome analysis to diagnose a young woman with progressive generalized dystonia, identifying a de novo TCF20 variant and supporting the gene’s inclusion in dystonia testing panels.

Orange document icon with pencil
Integrative and systematic genomic approaches to improve diagnosis in rare and undiagnosed diseases: results from the RareBoost project

Reanalysis solved cases missed years earlier: Yigit et al. (2026) annotated 120 diagnostically refractory families with Genomize-SEQ and companion tools, surfacing non-coding, structural, and mitochondrial variants previously reported as negative.

Orange document icon with pencil
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality

PSMF1 joins the Parkinson's gene list: Magrinelli et al. (2026) linked biallelic variants to a spectrum from early-onset parkinsonism to perinatal lethality, with Genomize-SEQ analysing exomes for one contributing Turkish family.

Orange document icon with pencil
A novel de novo frameshift variant in ZMYM2 expands the neuropsychiatric spectrum of NECRC syndrome: a case report

Mammadova et al. (2026) used Genomize-SEQ trio whole-exome analysis to identify a novel de novo ZMYM2 frameshift variant causing NECRC syndrome without the usual renal or cardiac anomalies, expanding the disorder's spectrum to include predominant ADHD and motor stereotypies.

Become a part of Genomize community!